Keep the Role of Pharmacogenetic Testing for Mental Health Meds in Perspective

October 2018

You'll hear debate about using pharmacogenetic testing to guide treatment for depression, ADHD, and other mental health conditions.

These tests are different than the direct-to-consumer genetic tests (23andMe, etc)...which are being promoted to tell people if they are at higher risk for medical conditions such as Alzheimer's or breast cancer.

A goal of pharmacogenetic testing is to identify gene variations that may predict how a patient will respond to certain meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Sort Through Influenza Vaccine Options for 2018-19
Diabetes Xultophy and Soliqua Will Be the First Basal Insulin/GLP-1 Agonist Combos
Epinephrine Clear Up Confusion About EpiPen Shortages and Auvi-Q
Migraine Prevent Mishaps With the New, Injectable Aimovig for Migraine Prevention
Practice Remember "Cooler Heads Prevail" When Conflict Arises
Dermatology Know How Diaper Rash Remedies Stack Up
Pharmacogenetics Keep the Role of Pharmacogenetic Testing for Mental Health Meds in Perspective
Natural Medicines Focus on Safety if Patients Use Essential Oils
HIV & AIDS Expect to See More HIV Meds Containing "Integrase Inhibitors"

Keep the Role of Pharmacogenetic Testing for Mental Health Meds in Perspective

Practical advice for a better career, with unlimited access to CE

Table of Contents